You are here
Press Releases
2017
CARY, N.C. (04/03/2017) The CEO Roundtable on Cancer has accredited LEERINK Partners LLC in Boston, MA with the CEO Cancer Gold StandardTM recognizing its efforts to reduce the risk of cancer for its employees and covered family members.
The CEO Roundtable on Cancer has accredited CVS Health (NYSE: CVS), the nation’s largest pharmacy innovation company, with the CEO Cancer Gold Standard, recognizing its efforts to reduce the risk of cancer for its employees and covered family members. The company earned the distinguished Gold Standard accreditation for taking actions in five key areas of health and wellness to fight cancer in the workplace, including: discouraging tobacco use; encouraging physical activity; promoting healthy diet and nutrition; detecting cancer at its earliest stages; and providing access to quality care.
2016
The CEO Roundtable on Cancer has elected Joaquin Duato of Johnson & Johnson to its Board of Directors.
The CEO Roundtable on Cancer presented the Robert Wood Johnson Foundation with the 2016 Dr. Charles A. Sanders Life Sciences Award in recognition of their innovative and collaborative work in the CEO Roundtable on Cancer’s Life Sciences Consortium.
The CEO Roundtable on Cancer has accredited Focused Ultrasound Foundation in Charlottesville, VA, with the CEO Cancer Gold StandardTM, recognizing its efforts to reduce the risk of cancer for its employees and covered family members.
The CEO Roundtable on Cancer has accredited 3M Austin Center in Austin, TX with the CEO Cancer Gold Standard™ recognizing its efforts to reduce the risk of cancer for its employees and covered family members.
The CEO Cancer Gold Standard, the employer health and wellness accreditation program of the CEO Roundtable on Cancer, is now helping more than 5 million employees and their family members prevent and address cancer through workplace-based programming as the first six Gold Standard employers celebrate ten years of accreditation.
The CEO Roundtable on Cancer has accredited Hatteras Venture Partners, an early-stage venture capital investment company in Durham, N.C., with the CEO Cancer Gold StandardTM recognizing its efforts to reduce the risk of cancer for its employees and covered family members.
The CEO Roundtable on Cancer has accredited The Ohio State University in Columbus, Ohio, with the CEO Cancer Gold Standard™, recognizing its efforts to reduce the risk of cancer for its employees and covered family members.
2015
The CEO Roundtable on Cancer presented the Alliance for Clinical Trials in Oncology and Pfizer with the 2015 Dr. Charles A. Sanders Life Sciences Awards.
The CEO Roundtable on Cancer elected Robert A. Bradway as its Chairman at its recent annual meeting, CEO Roundtable-XIV.
CARY, NC (09/28/2015) Helsinn, a privately-owned pharmaceutical group with its headquarters in Lugano, Switzerland, has earned the prestigious Global CEO Cancer Gold StandardTM accreditation. This accreditation recognizes the Company’s worldwide commitment to reducing cancer risk by promoting healthy lifestyle choices, encouraging early detection through cancer screenings, and ensuring quality care, thereby improving quality of life and increasing productivity for employees around the globe.
CARY, N.C. (09/17/2015) The CEO Roundtable on Cancer has accredited ProMedica, a leading healthcare organization in northwest Ohio, with the CEO Cancer Gold StandardTM recognizing its efforts to reduce the risk of cancer for its employees and covered family members.
Project Data Sphere, LLC (PDS) is an independent not-for-profit initiative of the CEO Roundtable on Cancer’s Life Sciences Consortium (LSC). The CEO Roundtable on Cancer has expanded the executive leadership of PDS to continue building on PDS’s first-year data collection successes and broaden the academic, government and industry collaborations that continue to drive the progress of this innovative research library-laboratory.
CARY, N.C. (08/13/2015) The CEO Roundtable on Cancer has accredited PAREXEL International in Waltham, MA with the CEO Cancer Gold StandardTM recognizing its efforts to reduce the risk of cancer for its employees and covered family members.